Recep Tayyip Erdoğan University Institutional Repository
metadata only
Plasma PDGFRβ and PSD4 methylation levels for non-invasive staging of liver fibrosis
Background and Aim: While liver biopsy remains the reference standard for assessing hepatic fibrosis, the major prognostic factor in metabolic dysfunction-associated steatotic liver disease (MASLD), its inherent limitations have driven the search for innovative non-invasive diagnostic tests. In this
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients#1350560
- Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma#849635
- AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.#685641
- SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population#1126561
- Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes#834735
Record · ID 1405198
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive